Semaphorin 3E suppresses tumor cell death triggered by the plexin D1 dependence receptor in metastatic breast cancers
about
Lipid-sensors, enigmatic-orphan and orphan nuclear receptors as therapeutic targets in breast-cancerEMT-Inducing Molecular Factors in Gynecological CancersKremen1 and Dickkopf1 control cell survival in a Wnt-independent mannerA data-driven network model of primary myelofibrosis: transcriptional and post-transcriptional alterations in CD34+ cells.For robust big data analyses: a collection of 150 important pro-metastatic genesGermline variants in the SEMA4A gene predispose to familial colorectal cancer type X.Sema6A and Mical1 control cell growth and survival of BRAFV600E human melanoma cells.Dysfunctional SEMA3E signaling underlies gonadotropin-releasing hormone neuron deficiency in Kallmann syndrome.PlexinD1 Is a Novel Transcriptional Target and Effector of Notch Signaling in Cancer Cells.Epigenetically downregulated Semaphorin 3E contributes to gastric cancerSemaphorin 3D autocrine signaling mediates the metastatic role of annexin A2 in pancreatic cancerEnhanced expression of semaphorin 3E is involved in the gastric cancer development.Use of NRP1, a novel biomarker, along with VEGF-C, VEGFR-3, CCR7 and SEMA3E, to predict lymph node metastasis in squamous cell carcinoma of the tongue.Current drug design to target the Semaphorin/Neuropilin/Plexin complexes.Overexpression of Semaphorin-3E enhances pancreatic cancer cell growth and associates with poor patient survivalDependence receptors and colorectal cancer.The emerging role of class-3 semaphorins and their neuropilin receptors in oncology.The role of the semaphorins in cancer.The role of Sema4A in angiogenesis, immune responses, carcinogenesis, and retinal systems.Overexpression of the dependence receptor UNC5H4 inhibits cell migration and invasion, and triggers apoptosis in neuroblastoma cell.mTOR Complex Signaling through the SEMA4A-Plexin B2 Axis Is Required for Optimal Activation and Differentiation of CD8+ T Cells.View Point: Semaphorin-3E: An Emerging Modulator of Natural Killer Cell Functions?MiR-34a regulates the invasive capacity of canine osteosarcoma cell lines.Metalloprotease-mediated cleavage of PlexinD1 and its sequestration to actin rods in the motoneuron disease spinal muscular atrophy (SMA).Overexpression of Nogo receptor 3 (NgR3) correlates with poor prognosis and contributes to the migration of epithelial cells of nasopharyngeal carcinoma patients.Impact of semaphorin expression on prognostic characteristics in breast cancer.HCMV Infection and Apoptosis: How Do Monocytes Survive HCMV Infection?
P2860
Q26764743-6F72D617-A7B9-4408-BFCE-85D757F5DC9DQ26781912-5F25E6EB-D2BC-4A33-AE6B-94956E8A0CE1Q28975609-A1973840-1A6B-4393-8496-3A2D1B15869EQ31110460-DAD0B5B0-A67D-4D04-B311-996E7DEED040Q31155755-29C0D87B-06EA-4B7E-9164-9C5BE1978120Q34427193-AAE735C0-CB95-486C-8596-094536610387Q35550099-9943E2F0-E053-4326-BDBC-AB90DE9AC887Q35836124-BC023B84-BA64-490E-8979-02077E6AC1EAQ36165373-8938AF6E-3253-4C63-965F-003672450A55Q36299715-847E753D-B13F-48FF-9099-6FF4432BD8D1Q36737593-C3E57DE2-AE8D-43E2-BDED-78A09278C430Q37103968-D76CCE11-4331-4B43-B3B9-EA30EC432243Q37321171-37EAAC25-ECDE-4DEE-999C-523CA7FBA2F2Q37509064-F2B4E1CC-E3BD-470C-8408-A8535ACE3DF0Q37699442-25527BD2-A94F-43FA-B60B-A5AC3DB9F71EQ38243917-308D19E0-9B75-4713-9661-08CD593EDC16Q38256958-8ECDE052-8B88-4B7B-881C-FA4F0FC0212EQ38929961-EFA04500-1925-4D71-893B-52B1605B1420Q38979592-1F45EB96-3E6A-4813-B9D8-9B65D8526168Q39024754-EAF91000-A2C7-434A-9DC5-C25F6B1D3E03Q41136945-D4B70B28-F688-49E6-8E5B-1E93DF4D52BCQ47104862-3A31B5C9-1DFF-4E83-94F9-15EB96475AC4Q47224057-24A52D36-5790-4B96-AFC3-68826B5D832CQ47827360-BB702C5B-C3EE-459B-A00D-2C258B1611A7Q50074089-6C719F6F-B742-4958-84CE-1932C4C1E85DQ55333468-3BE247F3-D2DD-4B52-BFF9-7E7F0194BB31Q57065814-BEBF23BD-D47E-4783-B586-A894A2F1AF56
P2860
Semaphorin 3E suppresses tumor cell death triggered by the plexin D1 dependence receptor in metastatic breast cancers
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Semaphorin 3E suppresses tumor ...... r in metastatic breast cancers
@ast
Semaphorin 3E suppresses tumor ...... r in metastatic breast cancers
@en
Semaphorin 3E suppresses tumor ...... r in metastatic breast cancers
@en-gb
Semaphorin 3E suppresses tumor ...... r in metastatic breast cancers
@nl
type
label
Semaphorin 3E suppresses tumor ...... r in metastatic breast cancers
@ast
Semaphorin 3E suppresses tumor ...... r in metastatic breast cancers
@en
Semaphorin 3E suppresses tumor ...... r in metastatic breast cancers
@en-gb
Semaphorin 3E suppresses tumor ...... r in metastatic breast cancers
@nl
prefLabel
Semaphorin 3E suppresses tumor ...... r in metastatic breast cancers
@ast
Semaphorin 3E suppresses tumor ...... r in metastatic breast cancers
@en
Semaphorin 3E suppresses tumor ...... r in metastatic breast cancers
@en-gb
Semaphorin 3E suppresses tumor ...... r in metastatic breast cancers
@nl
P2093
P50
P3181
P1433
P1476
Semaphorin 3E suppresses tumor ...... r in metastatic breast cancers
@en
P2093
Agnès Bernet
Amélie Royet
Benjamin Gibert
Isabelle Treilleux
Jonathan Luchino
Marie-Claude Amoureux
Mélanie Hocine
Patrick Mehlen
Sophie Chauvet
P304
P3181
P356
10.1016/J.CCR.2013.09.010
P407
P577
2013-11-11T00:00:00Z